• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC. FLEXCATH ADVANCE; CATHETER, STEERABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC. FLEXCATH ADVANCE; CATHETER, STEERABLE Back to Search Results
Model Number 4FC12
Device Problems Application Interface Becomes Non-Functional Or Program Exits Abnormally (1138); Failure to Advance (2524)
Patient Problem No Information (3190)
Event Date 10/03/2017
Event Type  malfunction  
Event Description
While undergoing a pv cryoablation procedure frost was noted on the introducer sheath and md could not advance or reposition the system, which appeared to be internally frozen.Entire system was replaced for the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLEXCATH ADVANCE
Type of Device
CATHETER, STEERABLE
Manufacturer (Section D)
MEDTRONIC, INC.
kristyn benson
8200 coral sea street
mounds view MN 55112
MDR Report Key6964834
MDR Text Key89829775
Report Number6964834
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Other
Type of Report Initial
Report Date 10/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/20/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Physician
Device Model Number4FC12
Device Catalogue Number4FC12
Device Lot Number61044
Was the Report Sent to FDA? Yes
Date Report Sent to FDA10/10/2017
Event Location Hospital
Date Report to Manufacturer10/10/2017
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Treatment
NO OTHER THERAPIES
Patient Age54 YR
-
-